This topic contains a solution. Click here to go to the answer

Author Question: Who can NOT bring cases, as petitioners, to the German high court? a. Individuals b. Political ... (Read 30 times)

swpotter12

  • Hero Member
  • *****
  • Posts: 527
Who can NOT bring cases, as petitioners, to the German high court?
 
  a. Individuals
  b. Political parties
  c. Parliamentary factions
  d. States
  e. All of the above can bring cases as petitioners

Question 2

Under New York Times v. Sullivan (1964), a public official cannot prevail in a libel suit unless he or she can show that the defendant's statements were made with
 
  a. criminal negligence.
  b. actual malice.
  c. reckless abandon.
  d. defamatory intent.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

CAPTAINAMERICA

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

e

Answer to Question 2

B




swpotter12

  • Member
  • Posts: 527
Reply 2 on: Jul 9, 2018
YES! Correct, THANKS for helping me on my review


bigsis44

  • Member
  • Posts: 317
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Fungal nail infections account for up to 30% of all skin infections. They affect 5% of the general population—mostly people over the age of 70.

Did you know?

Approximately 15–25% of recognized pregnancies end in miscarriage. However, many miscarriages often occur before a woman even knows she is pregnant.

Did you know?

Human neurons are so small that they require a microscope in order to be seen. However, some neurons can be up to 3 feet long, such as those that extend from the spinal cord to the toes.

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library